Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 1”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Very early researchStudy completedNCT02323217
What this trial is testing

I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers

Who this might be right for
Healthy VolunteersAlzheimer DiseaseMolecular Imaging
Imperial College London 20
Early research (Phase 1)Not Yet RecruitingNCT06793995
What this trial is testing

Effect of Food and Age on the Pharmacokinetics of LY03017

Who this might be right for
Alzheimer's Disease PsychosisParkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 26
Testing effectiveness (Phase 2)Study completedNCT04413344
What this trial is testing

Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease

Who this might be right for
Familial Alzheimer Disease (FAD)PSEN1 Mutation
Kyoto University 8
Early research (Phase 1)Study completedNCT01806909
What this trial is testing

Intranasal AD4-H5-VTN as an Adenovirus Vaccine

Who this might be right for
Healthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID) 51
Very early researchEnded earlyNCT02874820
What this trial is testing

I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD

Who this might be right for
Alzheimer Disease
Imperial College London 2
Large-scale testing (Phase 3)Looking for participantsNCT06976216
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Testing effectiveness (Phase 2)WithdrawnNCT02072252
What this trial is testing

Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men

Who this might be right for
Depressive SymptomsAnxiety Generalized
Northwestern University
Not applicableLooking for participantsNCT06965062
What this trial is testing

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Who this might be right for
Alzheimer DiseaseDementia Alzheimer TypeDementia Alzheimer's Type+2 more
Vincent Tay Khwee Soon 10
Testing effectiveness (Phase 2)UnknownNCT00606164
What this trial is testing

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Blanchette Rockefeller Neurosciences Insitute 9
Early research (Phase 1)Study completedNCT06774261
What this trial is testing

Phenserine on the Alzheimer's Treatment Horizon, Study 1

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Helse Stavanger HF 16
Early research (Phase 1)Study completedNCT02509117
What this trial is testing

First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979

Who this might be right for
Healthy Subjects
Pfizer 55
Early research (Phase 1)Study completedNCT01467726
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects

Who this might be right for
Alzheimer's Disease
Alfasigma S.p.A. 40
Testing effectiveness (Phase 2)Study completedNCT00104273
What this trial is testing

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
DementiaAlzheimer's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 376
Early research (Phase 1)Study completedNCT04931459
What this trial is testing

Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD

Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 65
Early research (Phase 1)Study completedNCT01443936
What this trial is testing

Experimental AD4-H5-VTN Vaccine in Healthy Volunteers

Who this might be right for
H5N1 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05345509
What this trial is testing

A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

Who this might be right for
Alzheimer Disease
Inventage Lab., Inc. 62
Early research (Phase 1)Looking for participantsNCT04396873
What this trial is testing

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Who this might be right for
Parkinson's DiseaseDementiaAlzheimer's Disease+2 more
National Institute of Mental Health (NIMH) 184
Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Early research (Phase 1)Study completedNCT06194552
What this trial is testing

A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07

Who this might be right for
Alzheimer Disease
NeuroTherapia, Inc. 32
Not applicableEnded earlyNCT04270604
What this trial is testing

Biological Sample Collection for Research and Biobanking

Who this might be right for
Parkinson DiseaseDiabetes Mellitus, Type 1Macular Degeneration+4 more
New York Stem Cell Foundation Research Institute 1,279
Load More Results